CL

Business Profile & Competitive Position

Colgate-Palmolive Company (CL) operates in the Consumer Defensive sector under the Household & Personal Products industry. The company runs two business segments. The first—Oral, Personal and Home Care—includes toothpaste, toothbrushes, soaps, deodorants, skin health items, household cleaners and fabric conditioners. The second is Hill’s Pet Nutrition, a specialty dog and cat food business. According to its most recent 10-K, Colgate markets products in over 200 countries and territories through retailers, wholesalers, e-commerce platforms, veterinarians and certain direct-to-consumer channels.

In 2025, Oral Care contributed 44% of worldwide net sales, Personal Care 17%, Home Care 16% and Pet Nutrition 23%. Walmart and its affiliates alone represented approximately 11% of 2025 net sales, with no other customer exceeding 10%. This revenue mix points to a portfolio anchored in high-frequency purchases—products consumers restock regularly regardless of economic cycle. The company also reports approximately 33,600 employees across more than 100 countries, with over 84% located outside the United States.

On the profitability side, the net margin is 9.7% and return on equity is 631.1%. The ROE figure is extraordinarily high and typically signals a leveraged balance sheet—often driven by share repurchases, low book equity or significant debt usage—rather than pure price power alone. Net margin is the cleaner metric for operational performance: a 9.7% margin is respectable for a packaged-goods giant but not exceptional relative to all of consumer staples. The combination of a single-digit net margin and an ROE in the hundreds means investors should inspect leverage, equity levels and capital-return policy when sizing up the moat.

Financial Posture

Colgate-Palmolive’s current market capitalization is approximately $72.0 billion. The trailing P/E ratio is 35.4, which prices the stock at a material premium to the broader market and to many consumer-staples peers. A P/E in the mid-30s implies the market is paying up for stability, global brand reach or perceived earnings resilience rather than for bargain valuation.

The beta is 0.32, indicating far lower volatility than the overall equity market. This fits the defensive profile: household and personal-care demand tends to be uncorrelated with GDP swings. The current share price is $89.98, with the 50-day exponential moving average at $88.38 and the RSI at 61.6. The RSI reading is near but not yet in overbought territory, and price is trading above its 50-day EMA.

Given the P/E of 35.4 and net margin of 9.7%, valuation appears stretched unless earnings growth accelerates or the market continues to assign a scarcity premium to low-beta cash flows. The 631.1% ROE, as noted, is not by itself a sign of superior economics; it needs to be read alongside the company’s liability structure and capital-return history.

Strategic Priorities & Outlook

Colgate-Palmolive’s most recent 10-K filing outlines a clear set of priorities. The company aims to drive organic sales growth and deliver consistent, compounded earnings-per-share growth. Operational efficiency, free-cash-flow generation and efficient balance-sheet use are listed as core financial goals. Execution depends on global brand reach, science-based innovation, an agile supply chain and what management calls best-in-class omni-channel demand generation.

Two additional themes stand out. First, the company is building capabilities in data, analytics and artificial intelligence. Second, it is working to evolve what it describes as a high-impact, inclusive culture. Operationally, the 2025 segment split shows the business is no longer just a toothpaste story: Oral Care at 44% remains dominant, but Pet Nutrition at 23% is nearly as large as Personal Care and Home Care combined. That diversification into veterinary and pet channels may matter for both growth and margin profiles going forward.

Macro & Geopolitical Exposure

As a Household & Personal Products company, Colgate-Palmolive is exposed to the usual macro forces that shape packaged goods. Input-cost volatility is a persistent factor: surfactants, resins, palm-oil derivatives, fragrances, and pet-food proteins and grains can move with commodity markets and currency swings. A business with 84% of its workforce outside the United States and sales in over 200 jurisdictions also carries meaningful foreign-exchange exposure to the U.S. dollar, even if local revenues are translated back at favorable or unfavorable rates.

Regulatory and trade policy is another layer. Consumer-products ingredients, labeling requirements, advertising claims and veterinary nutrition rules differ by country and can tighten without warning. Trade tariffs or logistical disruptions can affect the cost of imported raw materials and finished goods. On the demand side, private-label competition and the ongoing shift toward e-commerce and direct-to-consumer channels create pricing pressure that can squeeze margins over time.

Recent Developments

Recent media coverage has focused on Colgate’s dividend profile rather than any operational shock. On October 10, 2026, fool.com published “Want to Retire on Dividends? Here Are 4 Stocks to Buy Now and Never Sell,” which included Colgate in a dividend-retirement discussion. On October 6, 2026, zacks.com ran “Colgate vs. Clorox: Which Consumer Staples Giant Holds the Edge?,” a staples comparison piece. The same day, 247wallst.com featured Colgate in “Bond Yields Are Soaring: These 5 Fortress Dividend Stocks Offer Shelter for Income Investors.” Finally, on October 3, 2026, 247wallst.com included Colgate in a retrospective piece titled “In 1959, A Vermont Gas Station Attendant Spent $2,380 On His First 39 Shares Of Stock. Over The Next 5 Decades, He Built A 95+ Stock Portfolio Of Blue Chip Dividend Payers. By 2014, Ronald Read’s Portfolio Was Worth Nearly $8 Million.”

None of these headlines report new earnings guidance, product recalls or M&A activity; together they reflect market attention on defensive, dividend-oriented equities in a higher-yield environment.

Earnings Behavior & Post-Earnings Drift

Colgate-Palmolive has beaten earnings estimates in all of the last eight reported quarters, giving it a 100% beat rate over that span. The average earnings surprise is 3.3%. Despite the consistent beats, the stock has not always jumped immediately. The average 5-day price move after earnings across those eight quarters is +2.32%, classified as an upward post-earnings drift.

The four most recent reports illustrate the pattern. On July 31, 2026, actual EPS was $0.99 versus the $0.947 estimate—a 4.5% surprise. The stock fell 1.56% the next day but gained 2.16% over the following five sessions. On May 1, 2026, actual EPS was $0.97 versus $0.943 estimate, a 2.9% surprise; the next-day move was -2.17%, while the 5-day move was only +0.33%. On January 30, 2026, actual EPS came in at $0.95 versus $0.912 estimate, a 4.2% surprise, producing a +1.77% next-day move and a +4.56% 5-day drift. On October 31, 2025, actual EPS was $0.91 versus $0.889 estimate, a 2.4% surprise, with the stock down 2.69% the next day but up 2.22% over the following five sessions.

The takeaway is that earnings beats have been reliable, yet the immediate reaction has been mixed—the market sometimes revises its view over several days rather than on the headline. The next scheduled report is October 30, 2026 before the open, with a consensus EPS estimate of $0.929. Traders watching the unofficial consensus should keep in mind that even a beat has historically been met with a negative next-day price move roughly half the time.

For a deeper, institution-grade view of the factors discussed above, readers should examine the full institutional verdict for Colgate-Palmolive.